netilmicin + dexamethasone
Netaxen contains two active substances: netilmicin and dexamethasone.
Netaxen is used in adults to reduce inflammation and kill bacteria in the eye, where there is swelling and irritation, and where a bacterial infection is likely to occur.
If there is no improvement after finishing the treatment or if you feel worse, you should contact your doctor.
Netaxen can be used in adults, including the elderly.
The medicine is not recommended for use in children under 18 years of age.
Before starting treatment with Netaxen, discuss it with your doctor or pharmacist.
You should talk to your doctor if you experience swelling and weight gain around the trunk and face, as these are usually the first symptoms of a condition called Cushing's syndrome. After stopping long-term or intensive treatment with Netaxen, there may be a decrease in adrenal function. Before stopping treatment, you should discuss it with your doctor. These risks are particularly important in children and patients treated with ritonavir or cobicistat.
If you experience blurred vision or other vision disturbances, you should contact your doctor.
Netaxen is not recommended for use in children and adolescents (from birth to 18 years of age).
For external use only.
Netaxen should only be used on the surface of the eye. This medicine should never be injected or swallowed.
Netaxen may interact with other medicines. You should tell your doctor or pharmacist if you are taking or have recently taken any other eye products or other medicines, including those obtained without a prescription. Netaxen can be used with other eye products provided the instructions described in section 3 are followed.
You should tell your doctor or pharmacist if you are taking:
cisplatin (a medicine used to treat cancer);
If you are pregnant or breastfeeding, think you may be pregnant, or are planning to have a baby, ask your doctor or pharmacist for advice before using this medicine.
Use during pregnancy
Use of Netaxen is not recommended during pregnancy unless your doctor considers it necessary.
Use during breastfeeding
Netaxen should not be used during breastfeeding.
After using Netaxen, you may experience temporary blurred vision. Do not drive or use machines until your vision is clear.
This medicine contains 0.18 mg of phosphates in each drop, which corresponds to 3.66 mg/mL. If you have severe damage to the clear front layer of your eye (cornea), phosphates may, in very rare cases, cause clouding of the cornea due to calcium deposits during treatment.
This medicine should always be used exactly as your doctor or pharmacist has told you.
If you are not sure, ask your doctor or pharmacist.
The recommended dose is one dropinto the affected eye four times a dayor as directed by your doctor. The duration of treatment is usually between 5 and 14 days.
Do not change the dose of the eye drops without consulting your doctor.
Netaxen is not recommended for use in children and adolescents (from birth to 18 years of age).
Netaxen in single-dose containers can be used while wearing contact lenses, as it does not contain preservatives. However, during eye infections or inflammatory conditions, it is strongly advised not to wear contact lenses. Contact lenses should not be worn during treatment with corticosteroid eye drops due to the increased risk of infection.
Wait at least 10 minutes between using Netaxen and other eye drops or ointments. Eye ointments should be used last.
Check that the single-dose container is not damaged.
Improperly used eye drops can become contaminated with bacteria, which can lead to eye infections. Using contaminated eye drops can cause serious eye damage and vision loss.
If you accidentally put more drops in your eye than recommended, it is unlikely to cause problems.
Use the next dose at the usual time.
Do not use a double dose to make up for a forgotten dose.
Use the next dose at the usual time.
If you have any further questions about using this medicine, ask your doctor or pharmacist.
Like all medicines, Netaxen can cause side effects, although not everybody gets them.
The frequency of the following side effects cannot be estimated from the available data.
Eye disorders
Increased pressure in the eye, cataract formation after long-term treatment, blurred vision, occurrence or worsening of viral eye infections caused by the herpes simplex virus or fungal infections, delayed wound healing.
In very rare cases (less than 1 in 10,000) in some patients with severe damage to the clear front layer of the eye (cornea), cloudy spots appeared on the cornea due to calcium deposits during treatment.
Immune system disorders
Local allergic reactions: conjunctival redness, burning, itching.
Endocrine disorders
Excessive hair growth on the body (especially in women), weakness and muscle wasting, purple streaks on the skin, high blood pressure, irregular menstrual periods or absence of menstruation, changes in protein and calcium levels in the body, growth retardation in children and adolescents, and swelling and weight gain around the trunk and face (Cushing's syndrome) (see section 2, "Warnings and precautions").
In all the above cases, treatment should be discontinued.
If you experience any side effects, including any not listed in this leaflet, please tell your doctor or pharmacist. Side effects can be reported directly to the Department of Post-Marketing Surveillance of Medicinal Products, Medical Devices, and Biocidal Products, Al. Jerozolimskie 181C, PL-02-222 Warsaw, Tel.: +48 22 49 21 301, Fax: +48 22 49 21 309, website: https://smz.ezdrowie.gov.pl
Side effects can also be reported to the marketing authorization holder.
By reporting side effects, you can help provide more information on the safety of this medicine.
Keep this medicine out of the sight and reach of children.
Do not use this medicine after the expiry date which is stated on the carton, sachet, and container after: EXP. The expiry date refers to the last day of that month.
Store below 30°C.
Single-dose containers should be stored in the sachet to protect from light and moisture.
This medicine does not contain preservatives.
After opening the single-dose container, use the medicine immediately and discard the container with any remaining contents.
Medicines should not be disposed of via wastewater or household waste. Ask your pharmacist how to dispose of medicines no longer required. This will help protect the environment.
Netaxen is a clear, colorless or slightly yellow solution.
Netaxen eye drops in single-dose container:
Five single-dose containers containing 0.3 mL of Netaxen eye drops, solution in an aluminum sachet in a cardboard box.
Each pack contains 15 or 20 single-dose containers.
Not all pack sizes may be marketed.
SIFI S.p.A.
Via Ercole Patti 36
95025 Aci S. Antonio (CT)
Italy
info@sifigroup.com
Bulgaria, Germany, Latvia: Netildex
Greece, Spain: NETDEX
Cyprus, Czech Republic, Lithuania, Slovakia: Netaxan
Portugal: Dexametasona + Netilmicina SIFI
France: NETAXEN
Poland: Netaxen
Detailed information on this medicine is available on the website of the Office for Registration of Medicinal Products, Medical Devices, and Biocidal Products - www.urpl.gov.pl.
Need help understanding this medicine or your symptoms? Online doctors can answer your questions and offer guidance.